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YopM is one of the six “effector Yops” of the human-pathogenic Yersinia, but its
mechanism has not been defined. After delivery to J774A.1 monocyte-like cells, YopM
can rapidly bind and activate the serine/threonine kinases RSK1 and PRK2. However,
in infected mice, effects of Y. pestis YopM have been seen only after 24–48 h post-
infection (p.i.). To identify potential direct effects of YopM in-vivo we tested for effects
of YopM at 1 h and 16–18 h p.i. in mice infected systemically with 106 bacteria. At 16 h
p.i., there was a robust host response to both parent and yopM-1 Y. pestis KIM5.
Compared to cells from non-infected mice, CD11b+ cells from spleens of infected mice
produced more than 100-fold greater IFNγ. In the corresponding sera there were more
than 100-fold greater amounts of IFNγ, G-CSF, and CXCL9, as well as more than 10-fold
greater amounts of IL-6, CXCL10, and CXCL1. The only YopM-related differences were
slightly lower CXCL10 and IL-6 in sera from mice infected 16h with parent compared to
yopM-1 Y. pestis. Microarray analysis of the CD11b+ cells did not identify consistent
transcriptional differences of ≥4-fold at 18 h p.i. However, at 1 h p.i. mRNA for early
growth response transcription factor 1 (Egr1) was decreased when YopM was present.
Bone marrow-derived macrophages infected for 1 h also expressed lower Egr1 message
when YopM was present. Infected J774A.1 cells showed greater expression of Egr1 at 1 h
p.i. when YopM was present, but this pattern reversed at 3 h. At 6 h p.i., Cxcl10 mRNA
was lower in parent-strain infected cells. We conclude that decreased Egr1 expression is
a very early transcriptional effect of YopM and speculate that a pathway may exist from
RSK1 through Egr1. These studies revealed novel early transcriptional effects of YopM but
point to a time after 18 h of infection when critical transitional events lead to later major
effects on cytokine gene transcription.
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INTRODUCTION
The human-pathogenic Yersinia possess highly similar virulence
plasmids that encode a type 3 secretion system (T3SS) for delivery
of proteins into mammalian cells (Perry and Fetherston, 1997).
Six of these, termed effector Yersinia outer proteins (Yops), func-
tion to undermine innate defenses by inhibiting cell signaling
necessary for phagocytosis, activation ofmacrophages (Ms) and
effective anti-bacterial responses by polymorphonuclear leuko-
cytes (PMNs) (Viboud and Bliska, 2011). Enzymatic functions
and molecular targets are known for five of the effector Yops;
but the mechanism for YopM has not been readily revealed.
YopM consists almost entirely of leucine-rich repeats (LRRs) that
assemble into a curved parallel beta-sheet structure (Evdokimov
et al., 2001). The YopM proteins of the three human-pathogenic
Yersinia species differ in the number of internal repeats and in
the sequences of the internal LRRs but have high homology in
the N- and C-terminal LRRs as well as the leader sequence rec-
ognized by the T3SS and a short C-terminal tail sequence. The
pathogenic significance of the variations is not yet known. YopM
of Y. pestis and some Y. pseudotuberculosis is a 46 kDa highly acidic
protein with 15 LRRs (Evdokimov et al., 2001). After infection of
HeLa epithelioid cells or J774A.1 monocyte (MO)-M-like cells
by Y. pestis, YopM was shown to traffic to the perinuclear region
of the cell via a vesicular pathway, and variable amounts subse-
quently were found in the nucleus by 3–4 h post-infection (p.i.)
(Skrzypek et al., 1998). YopMpossesses at least one non-canonical
nuclear localization sequence, but no importin could be identi-
fied for its uptake mechanism (Skrzypek et al., 2003; Benabdillah
et al., 2004); it could enter the nucleus in association with a host
molecule to which it binds in the cytosol (Skrzypek et al., 2003).
Pure YopMhas been found to spontaneously penetrate eukary-
otic cells due to sequences within the N-terminal leader region
(Rüter et al., 2010). Although YopM is delivered to mammalian
cells by the T3SS, an intriguing hypothesis has been put forth
that type 3 secretion involves an extracellular stage for the Yops
in which they are located at the bacterial surface between the
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bacterium and the host cell (Akopyan et al., 2011). Accordingly
YopMmight enter the cell from this surface-located compartment
by using its spontaneous cell-penetration mechanism that triggers
uptake at lipid rafts via caveolae (Rüter et al., 2010). Trafficking
of pure YopM in HeLa cells follows a timecourse similar to that
after infection: it was found in early endosomes after 15–30min,
late endosomes by 30–60min, and a perinuclear localization by
60min (Rüter et al., 2010). At 3 h, small amounts also were found
in the nucleus (Rüter et al., 2010). Themolecules that YopMbinds
during its trafficking have not been identified, and the extent
to which YopM is exposed to the cytosol or partitions into the
cytosol is not known. However, it does bind to all known isoforms
of two cytosolic serine/threonine kinases, ribosomal protein S6
kinase (RSK or p90RSK) and protein kinase C-like (PRK or PKN)
(McDonald et al., 2003; Hentschke et al., 2010); and YopM-
associated complexes were found to contain combinations of the
various RSK and PRK familymembers (Hentschke et al., 2010). In
association with YopM, the two types of kinases were sequentially
activated, with initial activation of RSK1 which in turn activated
PRK2 (McDonald et al., 2003). RSK family members lie down-
stream of ERK1/2 in the Ras-MAPK pathway. However, YopM did
not affect activation of ERK but instead prevented dephophos-
phorylation of all RSK isoforms, perhaps by shielding them from
phosphatases (Hentschke et al., 2010). YopM-RSK1 complexes
were obtained within 30min of infection of RAW267.4MO-M-
like cells by Y. pseudotuberculosis (McCoy et al., 2010), suggesting
that such complexes form rapidly in the cytosol after contact
between Yersinia and a host cell. Although RSK1 does shuttle
between cytosol and nucleus, it was found that binding to RSK1
was not required for YopM to localize to the nucleus (McCoy
et al., 2010). RSK and PRK do not normally function together;
accordingly YopM was proposed to provide a scaffold for assem-
bling a novel complex with novel substrate specificity, because
several tested normal targets of these kinases (Bad, Jun, CREB,
Akt) were found not to be activated by the presence of YopM
(McDonald et al., 2003).
At present, it is not understood how these in-vitro observa-
tions underlie the effect YopM has in disease. The effect of the
absence of YopM on lethality varies considerably with the route
of infection and strain of mice that are used. YopM is required
for full virulence of wildtype Y. pestis CO92 in bubonic plague in
C57BL/6 mice, but it is not required for lethality in pneumonic
plague (Ye et al., 2011). It is a major virulence determinant for
systemic plague caused by conditionally virulent Y. pestis KIM5, a
popular model strain for studies of plague in BSL2 containment.
The KIM5 strain lacks a chromosomally encoded iron-acquisition
system needed for virulence from an intradermal route of infec-
tion but is fully virulent after intravenous infection of mice (Une
and Brubaker, 1984; Perry and Fetherston, 1997). In this model,
the absence of YopM results in a modest loss of virulence in out-
bred Swiss Webster mice (Nemeth and Straley, 1997), whereas
virulence is decreased by 4 orders of magnitude in C57BL/6
mice (Kerschen et al., 2004). Accordingly, these mice provide a
powerful experimental system in which to dissect the molecu-
lar basis of YopM’s pathogenic effect. In C57BL/6 mice infected
intravenously with doses that were above the LD50 of the parent
Y. pestis KIM5 but below that of yopM-1 Y. pestis KIM5-3002,
growth of the mutant was curbed in liver and spleen starting at
day 2 p.i. (Kerschen et al., 2004; Ye et al., 2009, 2011). This was
accompanied by a robust acute inflammatory response involving
PMNs and inflammatory dendritic cells (iDCs) that eventually
cleared the bacteria (Kerschen et al., 2004; Ye et al., 2009, 2011).
In mice infected with the YopM+ strain, numbers of iDCs and
natural killer (NK) cells began to decline from spleens start-
ing at day 2 p.i., the bacteria continued growing, and the mice
ultimately died (Kerschen et al., 2004; Ye et al., 2009, 2011).
Concomitantly, levels of mRNA for pro-inflammatory cytokines
remained low in spleens of mice infected with YopM+ Y. pestis but
increased strongly in spleens of mice infected with the yopM-1
strain (Kerschen et al., 2004). Depletion studies implicated iDCs
as major cells responsible for controlling growth of yopM-1
Y. pestis in spleen and showed that YopM was associated with
inhibition of their recruitment (Ye et al., 2009, 2011). These
findings prompted the hypothesis that in spleen YopM deliv-
ery to Ms causes downregulated production of chemokines for
inflammatory MOs, the cell type that gives rise to iDCs in organs
(Ye et al., 2011).
These effects of YopM likely began earlier than day 2 p.i.:
data pooled frommultiple experiments indicated that the growth
deficit of yopM-1 Y. pestis was beginning at day 1 p.i. (Ye et al.,
2011). We wanted to determine effects of YopM at earlier times
to bridge the gap between the first hours of infection stud-
ied using in-vitro cell models and the previous in-vivo studies.
The present study was designed to probe for YopM effects on
chemokine/cytokine gene expression and protein production in
this period, 1 h to 16–18 h p.i.
MATERIALS ANDMETHODS
BACTERIAL STRAINS AND CULTURE
The bacterial strains and plasmids used in this study are listed
in Table 1. Escherichia coli was used for propagating plasmids that
were transferred to Y. pestisKIM8-3003.12 as previously described
(Forman et al., 2008). All Y. pestis strains lacked the ca. 102 bp pgm
locus specifying the Ybt siderophore-based iron acquisition sys-
tem that is needed for virulence of Y. pestis in peripheral tissues
such as skin (Perry and Fetherston, 1997). A strain lacking the
pgm locus (pgm) is conditionally virulent: avirulent in periph-
eral tissues but essentially fully virulent from an intravenous route
of infection. Y. pestis was grown at 28◦C in supplemented Heart
Infusion Broth as described previously (Forman et al., 2008) and
was transferred to 37◦C for 1 or 3 h, as indicated. Where appro-
priate, carbenicillin (Cb) was added to cultures to ensure plasmid
maintenance.
INFECTION OF MICE
All experiments with mice were reviewed and approved by
the University of Kentucky Institutional Animal Care and Use
Committee. Groups of four 6–8 week old female C57BL/6N.HSD
mice (Harlan Sprague Dawley, Inc) were anaesthetized with
isoflurane using a rodent anaesthesia machine and infected intra-
venously in the retro-orbital plexus (RO) with indicated doses as
described (Ye et al., 2011). The bacterial doses were confirmed
and bacterial burdens in liver and spleen determined by plat-
ing serially diluted samples, and splenic leukocytes were isolated,
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Table 1 | Bacterial strains and plasmids used in this study.
Strain Relevant properties Source or references
Y. pestis
KIM5 Pgm− Lcr+; pCD1 pMT1 pPCP1a; conditionally virulent pgm
2.MED strain; also called KIM D27; YopM+ parent strain
Brubaker, 1991
KIM5-3002 yopM-1 derivative of Y. pestis KIM5 Kerschen et al., 2004
KIM8-3003.12 pPCP1− Multiple-Yop mutant; yopM-1 Philipovskiy et al., 2005
(KIM8-MYM) yopH yopE yopT ypkA yopJ
E. coli
DH5α F− 80d lacZM15 endA1 recA1 hsdR17(r−m m+k ) supE44 thi-1
gyrA96  (lacZYA-argF )U169; cloning host
Life technologies
PLASMIDS
pBluescript II SK- Phagemid cloning vector Stratagene (Agilent)
pBS10 (pYopM) yopM and native promoter in pBluescript II SK- Reisner and Straley, 1992
pPCP2::Kan kan-marked pPCP2 (from Y. pestis CO92) Forman et al., 2008
aThe native virulence plasmids of Y. pestis are the 9.6 kb pPCP (encodes the protease Pla), the 70.3 kb Lcr plasmid pCD (encodes the Ysc T3SS and Yops), and the
96.2 kb pFra (also called pMT; encodes the capsular fibril F1) (Perry and Fetherston, 1997).
all as done previously (Ye et al., 2011). Two tissue-dissociation
methods were used for experiments to obtain CD11b+ cells, a
Stomacher 80 Lab blender as in previous work (e.g., Ye et al.,
2011), and a GentleMACS dissociator (Miltenyi Biotec, Inc.) by
using the manufacturer’s protocol. The cell populations recov-
ered by these methods were not identical; accordingly, themethod
used will be specified. In some experiments, livers and spleens
from infected mice were fixed in buffered formalin, and paraffin-
embedded sections were stained with hematoxylin and eosin.
Sections were examined with a Nikon Eclipse E800 micro-
scope and representative areas photographed with a Photometrics
CoolSNAP cf camera.
ISOLATION OF CD11b+ CELLS
Splenic leukocytes were depleted of T cells, B cells, and PMNs
by immunomagnetic beads (Miltenyi), with amounts and pro-
cedures as recommended by the manufacturer’s protocol. This
process also removed dead cells, which bind non-specifically to
the beads. CD11b+ cells were then recovered on anti-CD11b
antibody-coupled immunomagnetic beads. The manufacturer
has verified that these beads will recover macrophages from
spleen. Briefly, leukocytes from four spleens per infecting bacte-
rial strain were pooled in ice-cold cell-column buffer (PBS pH
7.2, 0.5% BSA, 2mM EDTA). The cells were pelleted and resus-
pended in the buffer, and biotinylated anti-Ly6G was added.
After gentle mixing by inversion on a tube rotator for 10min
at 4–8◦C, microbeads conjugated with anti-CD5, anti-CD19,
or anti-biotin antibodies were added, the cell suspensions were
mixed on the rotator for 15min at 4–8◦C, washed by centrifuga-
tion, and resuspended in 1mL cell-column buffer. The suspen-
sions were applied to LS separation columns (Miltenyi) at room
temperature, and flowthrough cells (containing CD11b+ cells)
were collected through a 20 gauge needle into tubes on ice. The
columns were washed with cold buffer, giving a total effluent of
13mL. The collected cells were centrifuged and resuspended in
0.1mL buffer per column. Samples of diluted cells were stained
with trypan blue for viability assessment and were counted in
a hemocytometer. The cells were then positively selected for
CD11b+ cells with anti-CD11b-conjugatedmicrobeads in combi-
nation with aMACS Separator to retain anti-CD11b bead-labeled
cells prior to flushing the cells off the column. This process typ-
ically yielded 1–2× 107 cells per pool from four mice, consistent
with CD11b+ cells constituting ca. 5% of the splenic leukocytes
(Ye et al., 2011), and the preparations consistently contained
>95% viable cells. After removal of samples for differential cell
counting and flow cytometry, the remaining cells were suspended
in RLT/BME (Qiagen) following the manufacturer’s protocol.
They were snap-frozen in liquid N2 and stored at −80◦C.
ANALYSIS OF CELL POPULATIONS
Differential counts for major leukocyte types were made for
cell populations that were recovered following immune-magnetic
bead treatment. Slides were prepared with a cytocentrifuge,
stained with Giemsa, and cells scored from randomly selected
fields. For the RNA microarray experiments, between 140 and
611 cells were scored per sample; for the multiplex chemokine
experiments, between 570 and 972 cells were scored. The cells
analyzed by RNA microarray also were analyzed for presence
of Ly6G, Cd11b, Gr1, and CD11c (the 1-h infections) or Gr1
and F4/80 (the 18-h infections) by flow cytometry. Cell prepa-
ration for flow cytometry was done as previously described
(Ye et al., 2011), and the analysis was carried out using a
BD Biosciences LSRII flow cytometer. Dead cells and debris
were gated using ethidium monoazide (EMA, Sigma) viability
staining. The data were analyzed by FlowJo software (Version
7.6.1; Tree Star). Antibodies used were from BD Pharmingen,
Inc.: fluorescein isothiocyanate (FITC)-conjugated anti-CD11b,
allophycocyanin (APC)-conjugated F4/80, phycoerythrin (PE)-
conjugated anti-Ly6G, peridinin chlorophyll protein-cyanine tan-
dem dye (PerCP-Cy5.5)-conjugated anti-Gr1, PE-cyanine tandem
dye (PE-Cy7)-conjugated anti-CD11c, and Fc Block™ (Rat Anti-
Mouse CD16/CD32).
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MULTIPLEX MAP CYTOKINE/CHEMOKINE ANALYSIS
This set of experiments used the Miltenyi GentleMACS
dissociator to dissociate spleens. Chemokines and cytokinesmade
in response to 1 or 16 h infection with parent and yopM-1
Y. pestis were analyzed by Milliplex MAP chemokine array that
assays 22 inflammation-related cytokines and chemokines. The
experimental series included several control and reference treat-
ments as well as serum samples from somemice. (1) The CD11b+
cells from mice infected for 1 or 16 h and from non-infected
control mice were made to 2 × 106 cells ml−1 in RPMI + 10%
FBS and cultured for 6 h in 12-well dishes at 37◦C, 5%CO2.
Culture supernatants containing secreted proteins were filtered
through a 0.45μm pore-size low-protein-binding filter and snap-
frozen. (2) Serum was collected from all 16 h-infected mice and
from non-infected mice, pooled in equal ratio from the four
mice per group, filtered, and snap-frozen. (3) Non-fractionated
splenic leukocytes from mice infected 1 h and from non-infected
mice were cultured, filtered, and frozen as above. For the non-
infected splenocytes, duplicate sets of wells contained 20 ng ml−1
phorbol myristyl acetate (PMA). (4) Non-fractionated splenic
leukocytes from mice given 25μg E. coli O111:B4 LPS (Sigma)
by the RO route were obtained 1 h later and cultured, filtered,
and frozen as for the CD11b+ cells. All of these experiments were
carried out in triplicate on different days, using 108 mice total.
The chemokine array analysis was performed by Millipore/Merck
Biomarker Services (EMD Millipore, a division of Merck KGaA).
RNA MICROARRAY ANALYSIS
This set of experiments used the Stomacher 80 Lab blender to
dissociate spleens. Total RNA was obtained from CD11b+ cells
stored in RNAlater (Qiagen) by using the RNeasy mini-prep kit
per the manufacturer’s instructions (Qiagen). RNA integrity was
assessed by comparing 18S and 28S rRNA species using gel elec-
trophoresis on a Bioanalyzer (Agilent Technologies, Inc.). RNAs
from duplicate experiments (each using four mice per infect-
ing Y. pestis strain) were pooled 1:1 (except for 1-h infection
with yopM-1 Y. pestis, where triplicate experiments were used
and the RNAs were pooled in equal ratios), and the pools were
divided into three aliquots which were handled independently
to generate three hybridization data sets. Fluorescent-labeled
Cy5 (red) aRNA sample probes were prepared by reverse tran-
scription with SuperScriptIII reverse transcriptase (Invitrogen),
1-round of amplification with amino-allyl nucleotides according
to manufacturer’s protocol (Epicentre Biotechnologies) and cou-
pling to Cy5 (red) dye (GE Healthcare). Likewise Cy3 (green)
labeled aRNA probe was prepared using the Universal mouse
reference RNA comprised of RNA pooled from 11 mouse cell
lines (Stratagene). Each Cy5 sample aRNA probe was paired
with Cy3 reference aRNA probe and hybridized to microarrays
in formamide-containing buffer overnight at 42◦C using a Maui
Hybridization System (BioMicro Systems Inc.). The custom-
designed microarray consisted of 70-mer oligonucleotides rep-
resenting 1555 immune response gene targets. Commercially
available and custom-designed oligos were purchased from
Operon Biotechnologies, Inc. and printed onto glass slides by
the Duke Microarray Facility (Duke University, Durham, NC).
Each microarray contained replicate targets spotted four times.
The gene target pool also included housekeeping genes (i.e.,
Actb, Gapd, Tuba, ribosomal proteins Rpl13a, Rpl18, Rps9) used
as internal references, negative background controls and known
“spiked-in” RNA oligos (Applied Biosystems). The hybridized
spot intensities were acquired using a GenePix 4000B scanner
(Molecular Devices Corp) and assessed using GenePix Pro 6.0
software. Median pixel intensities (with background subtracted)
were uploaded in the GeneSpring X software package (Agilent
Technologies, Inc), normalized by global LOWESS fit (Cleveland,
1979), log base 2 transformed, filtered such that probes exceeding
the background and spot quality criteria (i.e., “absent” probes)
were not included and merged into datasets. Gene lists and hier-
archical clusters of differentially expressed genes were generated.
R software through Bioconductor (http://CRAN.R-project.org)
was employed as another approach to analyze hybridization signal
intensities (Becker et al., 1988; Zhang et al., 2009). The normal-
ized log ratio expression data from the GeneSpring X analysis for
all the genes in any sample that met the filtering criteria of “flags”
on the microarray called present or marginal, but not absent,
and for which the signal was above background in at least 3 of
the 12 samples have been deposited in NCBI’s Gene Expression
Omnibus (Edgar et al., 2002) and are accessible through GEO
Series accession number GSE41564 (http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE41564).
QUANTITATIVE RT-PCR CONFIRMATION AND EVALUATION
Several gene targets were analyzed on the RNA used for
microarray as well as from additional replicate experiments
by two-step quantitative RT-PCR (qRT-PCR) using SYBR
Green detection and quantification in a LightCycler 2.0
instrument equipped with version 4.0 software (Roche).
Primer sequences were obtained from the RTPrimer Database
(www.rtprimerdb.org).
TISSUE-CULTURE INFECTION MODELS
Bone marrow-derived macrophages (BMMs) were used after
7–10 days culture of femoral bone marrow in 12-well dishes in
medium comprised of 60% Dulbecco’s Modified Eagle Medium
(high glucose supplemented with glutamine and HEPES; GIBCO
11960: Life Technologies, Inc.) 20% heat-inactivated FBS (GIBCO
26140-079: Life Technologies), 20% filtered L929 cell-conditioned
medium, and 1% penicillin-streptomycin-neomycin mixture
(GIBCO 15640: Life Technologies). J774A.1 mouse macrophage-
like cells (ATCC) were cultured in 24-well dishes in RPMI 1640
(supplemented with glutamine and HEPES: Mediatech, Inc. 10-
041-CV: Corning Life Sciences) + 10% heat-inactivated FBS.
Both cell types were grown to ∼95% confluence and rested for
3 h in medium without FBS prior to infection. Y. pestis that had
been grown to an OD620 of ca. 1.0 were pelleted and resuspended
to give the desired MOI (10–40) in the appropriate tissue-culture
medium without FBS and incubated, 1ml per well, in 12-well
plates at 37◦C + 5% CO2. Medium for uninfected control wells
was similarly incubated. After 1–3 h, the medium over the BMMs
or J774A.1 cells was replaced by bacteria-containing or control
medium, and the infection was initiated by a 5-min centrifu-
gation. After infection for 1–6 h, the medium was replaced by
1mL RNAlater (Qiagen) per well, and RNA was isolated by
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following the protocol for Qiagen RNeasy Mini Kit for adher-
ent cells.
STATISTICS
For genomic analyses, a right-tailed Fisher’s Exact Test was
employed to produce a significance p-value that described how
likely genes from a specific dataset participated in a desired func-
tion. For other assays, significance of differences was evaluated
with the two-tailed unpaired Student’s t test.
RESULTS
HIGH-DOSE SYSTEMIC PLAGUE MODEL
This project was undertaken to characterize early mRNA and
cytokine responses that lead to the transcriptional and cellular
recruitment differences seen at 2 days p.i. (Kerschen et al., 2004;
Ye et al., 2011). We developed a high-dose intravenous infec-
tion model to provide a detectable host response at these early
times. This route gives a synchronous infection in which the bac-
teria seed spleen and liver within 30min (Conlan, 1997; Burnett
et al., 2004). The dose of 106 potentially would provide immediate
interactions with a significant fraction of immune cells known to
be targeted by Y. pestis: Ms, MOs, PMNs, andDCs (Lukaszewski
et al., 2005; Marketon et al., 2005). Prior to infection, the bac-
teria were given a 3-h incubation at 37◦C to induce thermally-
upregulated genes such as those for the T3SS and Yops, because
during the natural infection yersiniae that reach internal organs
would have been pre-exposed to mammalian body temperature.
Figure 1A shows that the YopM-associated growth difference
was manifested as a 10-fold difference in bacterial burden at 30 h
p.i., demonstrating that a YopM-related host-response phenotype
was present in this infection model. Up to 16 h p.i., the two Y.
pestis strains grew at the same rate. This absence of a difference in
bacterial burden at 16 h has important implications which will be
discussed later. By 16 h, the host response to infection had clearly
initiated, based on the presence of inflammatory foci in spleens
of mice infected with either Y. pestis strain (Figure 2). These were
located at the periphery of the follicles and adjacent red pulp. The
live inflammatory cells in infected spleens were characterized by
flow cytometry. Figure 1B illustrates the gating strategy used to
define and quantify these cells, and Figure 1C shows the dynamics
of three populations during the development of disease: Ly6G+
F4/80− mature PMNs, Ly6G− F4/80+ Gr1+ MOs, and Ly6G−
F4/80− Gr1+ cells, comprised of iDCs, plasmacytoid DCs, some
CD8+ T cells, and myeloid-derived suppressor cells (MDSCs)
(Kung et al., 1991; Egan et al., 2008; Auffray et al., 2009). By
8 h p.i., all three populations had markedly increased in preva-
lence over the levels present in non-infected mice (open squares
on the ordinates). However, by 16 h p.i., and further at 30 h, the
PMNs andMOs had declined in prevalence in both infections. In
contrast, the net percentages of the heterogeneous Ly6G− F4/80−
Gr1+ population remained the same at 16 h as at 8 h p.i.. By 30 h
the mice were clearly sick, and the decreases in other populations
resulted in an apparent increase in percentage of Ly6G− F4/80−
Gr1+ cells. We did not investigate the basis of inflammatory cell
loss but note that it is well known that initially acute inflamma-
tory foci evolve into cell-poor lesions at later times in systemic
plague even for yopM-1 Y. pestis when the bacterial numbers
are similar to those in our study Ye et al. (2011). Based on these
observations, we elected to restrict our studies to around 16 h p.i.,
and earlier, when there were no differences in bacterial burdens
between infecting strains that could influence the host response
in a non-YopM-related manner. At 16 h, the bacteria were repli-
cating, and a robust host cellular response was underway. This
time point would be long enough after infection that the influ-
ence of YopM on gene expression in inflammatory cells as well as
resident cells could be manifested. As a very early point in infec-
tion we chose 1 h p.i., when inflammatory foci were not detected
(data for liver not shown) and the bacteria likely were interacting
mainly with resident cells.
CYTOKINES AND CHEMOKINES IN SPLENIC CELLS AND SERA OF MICE
INFECTEDWITH YopM+ AND YopM− Y. pestis
Putative target cells for YopM in spleens of mice infected for
1 or 16 h were characterized for their release of 22 chemokines
and cytokines after a 6-h incubation in-vitro. We wanted to
remove non-critical cells from the analysis in an effort to focus
on cells that mediate the pathogenic effect of YopM and thereby
increase the signal-to-noise ratio. Because mice lacking T cells
and B cells or depleted of Ly6G+ PMNs still control growth
of yopM-1 Y. pestis in spleen as efficiently as wild-type mice
(Kerschen et al., 2004; Ye et al., 2011), these cells are not crit-
ical cells for the pathogenic effect of YopM (or their absence
would allow the yopM-1 strain to grow like the YopM+ par-
ent strain). Accordingly, we removed B cells, T cells, and Ly6G+
PMNs from splenic leukocytes of infected mice and selectively
recovered CD11b+ cells for chemokine assays. These included
resident Ms and myeloid DCs (mDCs), MOs, any iDCs present
at 16 h, and MDSCs as well as immature PMNs not removed by
the anti-Ly6G-coupled beads (Frazer et al., 2011). In addition,
cytokine production by total splenic leukocytes was assayed for
mice infected 1 h, and sera were analyzed from mice infected for
16 h. Two classic stimulatory treatments were included as systems
controls: mice were treated with LPS for 1 h and their total splenic
leukocytes were assayed for production of chemokines, and total
splenic leukocytes fromnon-infected mice were treated with PMA
during the 6-h in-vitro culture period. These assays were needed
to validate the duration of culturing for chemokine/cytokine pro-
duction and the ability to detect host responses after only 1 h of
stimulus.
Table 2 gives the percentage of cell types recovered from the
anti-CD11b-conjugated beads after 1 or 16 h infection with par-
ent or yopM-1 Y. pestis. Surprisingly, the recovered popula-
tions were dominated by comparable numbers of MO/Ms and
immature PMNs (ring forms, band cells, and intermediate stages
between these). It cannot be ruled out that some of these were
MDSCs, which also are CD11b+ Gr1+ cells present in spleens of
healthy mice (Ribechini et al., 2010). These cells have been docu-
mented to function in suppression of T cell responses (Ribechini
et al., 2010) and, in one case, resolution of infection (Poe et al.,
2012). In the present study the cells were obtained during the
early phase of acute inflammation and most likely were immature
PMNs.
There were no significant differences in prevalence of cell
types between mice infected with YopM+ and yopM-1 Y. pestis
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FIGURE 1 | Infection dynamics and host cellular responses in spleen in
the high-dose systemic plague model. C57BL/6 mice were infected
intravenously with a dose of 106 of the parent Y. pestis KIM5 (closed circles)
or the yopM-1Y. pestis KIM5-3002 (open circles) that had been induced for
expression of thermally-upregulated properties for 3 h at 37◦C. Bacterial
burdens were determined as CFU Panel (A). Bacterial numbers differed
significantly for parent and yopM-1 Y. pestis at 30 and 45h p.i. (P < 10−4 and
P < 10−2, respectively). Splenic leukocytes were stained with
fluorochrome-conjugated antibodies against the surface markers Ly6G, F4/80,
and Gr1 as well as the dye EMA which stains cells that have lost membrane
integrity, and analyzed by flow cytometry. Panel (B) illustrates the gating
strategy used to define and quantify several host cell populations as percent
live leukocytes. Panel (C) shows how the percent of EMA− (i.e., “live”)
leukocytes changed over 30h of infection for three inflammatory cell types of
relevance to the host response to Y. pestis. Values for non-infected mice are
given by the open squares on the ordinates. Percentages of Ly6G+ F4/80−
PMNs at 16h were significantly different from those at 8 h for mice infected
with the yopM-1 strain (P < 0.05 by student’s t-test); those at 30h differed
significantly from 8h for infections by both Y. pestis strains (P < 10−2 for
parent and P < 10−4 for yopM-1). For Ly6G− F4/80+ Gr1+ MOs,
percentages at both 16 and 30h differed significantly from those at 8 h for both
infections (parent: P < 0.05 for 16h, P < 10−5 for 30h;yopM-1: P < 10−2 for
16h, P < 10−5 for 30h). For the Ly6G− F4/80− Gr1+ population, percentages
differed only for 30 compared to 8h p.i. (P < 10−2 for parent Y. pestis and
P < 10−3 for yopM-1). Each datum point gives the averages ± standard
deviation (SD) for pooled data from six mice in two independent experiments.
for either infection time. Although there was a trend toward
increased prevalence of PMNs at 16 h compared to cells from
1 h p.i., and non-infected mice, this effect was not statistically
significant. These findings are consistent with our previous obser-
vations that MOs accumulate in Y. pestis-infected spleens along-
side or even before the PMNs and that up to day 1 p.i. the
numbers of both cell types (as assayed by flow cytometry) do not
differ between mice infected with the two Y. pestis strains (Ye et al.,
2009).
Table 3 shows that non-infected splenocytes cultured for 6 h
with PMA produced detectable amounts of nine chemokines in
all three experiments, in contrast to ones cultured with medium
alone, which produced small amounts only of CCL5 and, in
two experiments, of CXCL9 and CXCL10. Splenocytes from mice
treated with LPS for 1 h consistently produced twelve of the
chemokines/cytokines during subsequent culture with medium
alone, and these generally were present in significantly greater
amounts than from splenocytes stimulated in-vitro with PMA.
These reference tests showed that the test system functioned well
and had the potential to provide meaningful results with cells
from infected mice.
Table 4 shows the chemokine/cytokine profiles for sera and
CD11b+ cells from these experiments. The analyses of sera from
mice infected with both YopM+ andyopM-1 Y. pestis confirmed
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FIGURE 2 | Histopathology of spleen at 16 h p.i. C57BL/6 mice were
infected for 16h as in the experiments of Figure 1, and spleens were
fixed in formalin and stained with hematoxylin and eosin.
Representative sections are shown. Left panel, spleen from a mouse
infected with parent Y. pestis; Right panels, spleen from a mouse infected
with yopM-1 Y. pestis. In each panel the surround indicates an
inflammatory focus at the edge of a lymphoid follicle.
Table 2 | Distribution of cell types among splenic CD11b+ cells
analyzed by multiplex chemokine/cytokine array.
Treatment MO/M PMN Other Lymphocytes
Non-infected mice 43 ± 8 36 ± 4 1 ± 0 19 ± 4
MICE INFECTED 1h
Parent Y. pestis 41 ± 6 36 ± 5 4 ± 3 21 ± 3
yopM-1 Y. pestis 46 ± 6 31 ± 2 1 ± 0 22 ± 8
MICE INFECTED 16h
Parent Y. pestis 45 ± 5 42 ± 8 1 ± 0 12 ± 6
yopM-1 Y. pestis 45 ± 6 45 ± 7 1 ± 0 10 ± 2
that a robust cytokine/chemokine response was underway by
16 h p.i., with levels of G-CSF and CXCL9 greater than 100-fold
above those in non-infected mice, and high levels of IL-6, CXCL1,
CCL2, CXCL10, and IFNγ. Curiously, GM-CSF and IL-1β were
not detectable in sera. Six chemokines (including TNFα) were
present at levels less than 5-fold above those in non-infected mice,
and amounts of five others, including IL-4 and IL-10, were com-
parable to those in non-infected mice. Of the 22 chemokines and
cytokines assayed in sera, two differed between mice infected with
the two Y. pestis strains: CXCL10 (significant at P = 0.0423) and
IL-6 (not quite significant at P = 0.066), but the differences were
less than 2-fold. Overall, these experiments revealed that mice
infected with a large dose of Y. pestis produced only a marginal
systemic cytokine response at 1 h p.i., but a strong and selective
systemic response that was independent of the presence of YopM
in the infecting strain by 16 h p.i.
At 1 h p.i., CD11b+ cells produced detectable amounts of 7
chemokines/cytokines, but none of these was consistently found
at levels above those for cells from non-infected mice. At 16 h
p.i., the CD11b+ cells produced these same chemokines/cytokines
more consistently; but due to the range of responses in the three
experiments, only IL-1β and IFNγ (for yopM-1 Y. pestis) lev-
els were significantly higher than for CD11b+ cell responses
from non-infected mice (at P < 0.05). There were no significant
YopM-related differences in chemokine/cytokine production by
CD11b+ cells at 16 h p.i.
TRANSCRIPTIONAL PROFILING OF SPLENIC CD11b+ CELLS FROMMICE
INFECTEDWITH YopM+ ANDYopM Y. pestis
Levels of mRNAs for a custom panel of immune response
genes were measured for CD11b+ cells obtained from spleens of
infected mice and compared to transcript levels in a commercially
produced “Universal mouse reference RNA.” In these experi-
ments, spleens were dissociated with a Stomacher lab blender,
producing a cell population skewed toward MOs/Ms rather
than immature PMNs (see Table 5). Figure 3 shows that the
majority of these cells were in fact CD11b+.
Also as expected, very few were positive for the Ly6G marker
on mature PMNs. The majority (40–60%) of the population
was also positive for Gr1 (not significantly different for mice
infected by YopM+ vs. yopM-1Y. pestis). Similar percentages
of Gr1+ cells were present among the CD11b+ cells obtained at
18 h p.i. [53 ± 7 and 63 ± 10% for mice infected with parent
andyopM-1 Y. pestis, respectively (determined by flow cytomet-
ric analysis for Gr1 and F4/80)]. These cells likely were mainly
MOs, iDCs, mDCs, and possibly MDSCs, based on the magnetic
bead selections that produced them. About 10% of the cells were
positive for the DC marker CD11c.
Table 6 gives the microarray findings for genes expressed
≥2-fold higher or lower by splenic CD11b+ cells from mice
infected 1 h with parent vs.yopM-1 Y. pestis. As expected for this
very early time of infection, not many transcriptional differences
were found. However, one gene was present as a large difference
in both of the analyses: early growth response transcription fac-
tor 1 (Egr1), which encodes a transcription factor that mediates
the immediate early response of cells to many stresses (Sukhatme,
1990). This gene is a likely candidate for upregulation by 1 h of
infection, as Egr1 is regulated at the transcriptional level, with
message levels increasing within 30min to 2 h after a stimulus
(Yan et al., 2000). Interestingly, the gene for the chemokine CCL2
also was differentially expressed sufficiently to pass the criteria in
the GeneSpring X analysis. It is a known transcriptional target of
Egr1 (e.g., Yan et al., 2000). These findings represent the earliest
transcriptional effects associated with YopM and point to a pos-
sible direct effect of YopM in cells that may interact directly with
Y. pestis.
The transcriptional response by splenic CD11b+ cells infected
for 18 h was remarkably restricted: only 176 of the 1561 gene
targets on the chips showed changes in expression ≥2-fold
compared to expression at 1 h p.i. 55 of these genes were in
common between mice infected with the two Y. pestis strains,
97 were unique to mice infected with the YopM+ strain, and
24 were unique to mice infected with yopM-1 Y. pestis (see
full dataset at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE41564). Table 7 shows those transcriptional responses
that differed by ≥2-fold between mice infected with the two Y.
pestis strains at 18 h. There was no agreement by the two data
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Table 3 | Control tests for multiplex analysis of chemokines and cytokinesa,b.
Cytokine/chemokine concentration, pg ml−1
Treatment G-CSF GM-CSF TNFα IL-1β IL-6 CXCL1 IFNγ
MEDIUM-ONLY CONTROLS
With 20 ng ml−1 PMA <3 <16 <3 <16 <16 <3 <3
Medium only <3 <16 <3 <16 <16 <3 <3
SPLENOCYTES
Non-infected mice
Incubated with 20 ng ml−1 PMA <3 28 ± 9 13 ± 5 <16 –c <3 5 ± 1
Incubated without PMA <3 <16 <3 <16 <16 <3 <3
Mice given LPS 1h
1mg/kg E. coli LPS given RO 6 ± 1 –c 27 ± 3 100 ± 37 133 ± 35 19 ± 2 43 ± 10
Mice infected 1h
Parent Y. pestis –c <16 158 ± 148d –c –c –c <3
yopM-1 Y. pestis 5 ± 0d <16 83 ± 35d –c 77 ± 13d 5 ± 2d <3
CCL5 CXCL9 CXCL10 CXCL2 VEGF IL-10 IL-17
MEDIUM-ONLY CONTROLS
With 20 ng ml−1 PMA <3 <16 <3 <80 <3 <3 <3
Medium only <3 <16 <3 <80 <3 <3 <3
SPLENOCYTES
Non-infected mice
Incubated with 20 ng ml−1 PMA 96 ± 48 76 ± 23 35 ± 16 243 ± 73 8 ± 4 19 ± 17 –c
Incubated with medium only 11 ± 3 33 ± 8d 7 ± 4d <80 <3 –c <3
Mice given LPS 1h
1mg/kg E. coli LPS given RO 154 ± 17 228 ± 55 288 ± 46 156 ± 34 –c 27 ± 5 9 ± 2
Mice infected 1h
Parent Y. pestis 44 ± 20 100 ± 35 33 ± 11 –c <3 13 ± 6d –c
yopM-1 Y. pestis 45 ± 24 103 ± 34 48 ± 26 428 ± 218d <3 8 ± 2d –c
a<signifies that data from all three experiments were below the detection limit. Other values without a superscript are average ± SD based on data that were above
the detection limit in all three experiments.
bResults for IL-4, IL-12(p40), IL-12(p70), IL-15, Eotaxin, CXCL5, CCL2, and M-CSF are not listed because all samples returned responses below the detection limit
for these chemokines/cytokines.
c–denotes that there was only one response above the detection limit; the other two experiments returned data that were below the detection limit.
d Average ± the range from two experiments; the third experiment returned data that were below the detection limit.
analyses, even for apparently strong differences (e.g., Chi3l3).
Nonetheless, because the presence of YopM appeared to affect a
few genes very strongly we repeated the 18-h infections and mea-
sured message abundance relative to the control gene Ubc for
Chi3l3 and Cxcl2 and also the potentially relevant p47 Phox gene
Ncf1 in splenic CD11b+ cells by qRT-PCR. None differed by ≥2-
fold for cells frommice infected with the two Y. pestis strains (data
not shown). Taken together, these findings signify that there were
no major transcriptional differences between CD11b+ cells from
the two groups of mice at 18 h p.i.
Table 8 shows that the microarray findings for Egr1 and Ccl2
at 1 h p.i. were reproduced in confirmation tests by qRT-PCR.
The YopM-related effect on Egr1 expression was a downregula-
tion compared to the level in CD11b+ cells from non-infected
mice. We also tested genes for three other proinflammatory
chemokines/cytokines and found a small upregulation of Il1β
in the absence of YopM. There were no significant differences
in expression of these genes between CD11b+ cells from mice
infected for 18 h with the two Y. pestis strains, consistent with the
hypothesis that no major transcriptional changes related to YopM
were occurring in this cell population at this time. However,
these cells clearly were responding to the infection, as Ccl2, Ccl3,
and Il1β were upregulated in expression compared to cells from
non-infected mice.
INFLAMMATORY GENE EXPRESSIONUSING in-vitro INFECTION
MODELS
In the interest of identifying a system to extend the studies to the
biochemical level with a pure cell population, we tested whether
BMMs infected in-vitro for 2 h would show YopM-related tran-
script differences at 6 h for the same genes examined in the
experiments of Table 8. Table 9 shows that the BMMs responded
to infection by upregulating expression of all five genes tested;
but there were no YopM-related differences, even for Ccl2. Egr1
in infected BMMs showed no difference from non-infected cells,
as expected for this transiently expressed gene after 6 h infection.
To test for a YopM-related difference in Egr1 expression,
BMMs were infected for 1 h (Table 9). In these experiments, the
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Table 4 | Chemokines and cytokines from sera and splenic CD11b+ cells of mice infected with YopM+ and yopM-1 Y. pestis a .
Cytokine/chemokine concentration, pg ml−1
Treatment G-CSF GM-CSF TNFα IL-1β IL-6 CXCL1 IFNγ
Sera
Non-infected mice 452 ± 93 <160 10 ± 1 <160 <32 74 ± 18 20 ± 8
Mice infected 16h
Parent Y. pestis 97,401 ± 27,167 <160 43 ± 5 <160 1341 ± 485 2087 ± 231 7291 ± 3042
yopM-1 Y. pestis 111,939 ± 42,016 <160 48 ± 5 <160 2476 ± 413 2351 ± 869 6876 ± 1326
CD11b+ CELLS
Non-infected mice <3 <16 38 ± 19 <16 33 ± 3 7 ± 2 <3
Mice infected 1h
Parent Y. pestis 10 ± 3c <16 149 ± 139c <16 –b 19 ± 14c <3
yopM-1 Y. pestis –b <16 53 ± 65 <16 –b 8 ± 4c <3
Mice infected 16h
Parent Y. pestis –b 22 ± 2c 27 ± 27 48 ± 22 150 ± 155 23 ± 12 1712 ± 1040
yopM-1 Y. pestis –b <16 373 ± 519 48 ± 16∗ 1076 ± 1478 41 ± 25 650 ± 249∗
CCL5 CXCL9 CXCL10 CXCL2 VEGF IL-10 IL-17
SERA
Non-infected Mice 54 ± 4 410 ± 53 220 ± 14 <800 <6 <32 8 ± 0
Mice infected 16h
Parent Y. pestis 80 ± 35 76,612 ± 3276 3116 ± 186 1151 ± 281c 28 ± 10 –b 11 ± 6
yopM-1 Y. pestis 88 ± 16 50,585 ± 14,345 3709 ± 215∗∗ 969 ± 86c 23 ± 0c <32 15 ± 2
CD11b+ CELLS
Non-infected mice 123 ± 73 335 ± 256 391 ± 225 –b <3 –b <3
Mice infected 1h
Parent Y. pestis 49 ± 25 168 ± 63 235 ± 156 –b <3 <3 <3
 yopM-1 Y. pestis 35 ± 8 117 ± 14 217 ± 85 –b <3 <3 <3
Mice infected 16h
Parent Y. pestis 31 ± 16 1609 ± 868 1112 ± 660 <80 <3 <3 –b
yopM-1 Y. pestis 74 ± 82 4373 ± 2751 2127 ± 1521 –b <3 –b 7 ± 4c
IL-4 IL-12(p40) IL-12(p70) IL-15 Eotaxin CXCL5 CCL2 M-CSF
SERA
Non-infected mice 9 ± 1c <32 139 ± 32 <32 568 ± 47 7994 ± 631 76 ± 5 8 ± 2
Parent Y. pestis –b 86 ± 28 267 ± 142 942 ± 1188 1584 ± 47 7660 ± 450 2047 ± 237 44 ± 10c
yopM-1 Y. pestis –b 81 ± 13c 262 ± 19 54 ± 19c 1537 ± 154 7756 ± 536 1804 ± 245 37 ± 4
CD11b+ cellsd <3 <16 <3 <16 <3 <400 <16 <3
a<signifies that data from all three experiments were below the detection limit. Other values without a superscript are average ± SD based on data that were above
the detection limit in all three experiments.
b–denotes that there was only one response above the detection limit; the other two experiments returned data that were below the detection limit.
cAverage ± the range from two experiments; the third experiment returned data that were below the detection limit.
d CD11b+ cells from all treatment groups returned responses below the detection limit for this set of genes, with the exception of mice infected for 16 h with parent
Y. pestis, for which a single experiment returned a value of 670 pg ml−1 for CXCL5.
*Significantly greater than the response from CD11b+ cells from non-infected mice (P < 0.05).
∗∗Data from mice infected with the two Y. pestis strains differed significantly at P < 0.05.
cultured macrophages were pretreated and infected in the pres-
ence of 2.5μM cytochalasin D, which has been used previously
in experiments to measure Yops delivery to J774A.1 cells (Cowan
et al., 2005). This refinement in the protocol was made to prevent
phagocytosis of some yersiniae and their loss from the popu-
lation delivering YopM, since YopM is believed to be delivered
primarily by extracellular bacteria (e.g., Skrzypek et al., 1998).
These tests revealed a statistically significant 2-fold lower Egr1
expression when YopM was present in the infecting Y. pestis and
extended our transcriptional findings from infected mice to an
in-vitro infection model.
In an attempt to elicit a stronger in-vitro transcriptional
phenotype for YopM that could be pursued biochemically, we
infected BMMs and also J774A.1 monocyte-like cells at a higher
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Table 5 | Distribution of morphological types among the CD11b+ cells
used for transcriptional analysis.
Treatment MO/M PMN Other Lymphocytes
MICE INFECTED 1h
Parent Y. pestis 72 ± 3 15 ± 6 0 ± 0 13 ± 3
yopM-1 Y. pestis 77 ± 11 10 ± 7 1 ± 1 12 ± 5
MICE INFECTED 18h
Parent Y. pestis 61a 20a 4a 15a
yopM-1 Y. pestis 66 ± 8 20 ± 12 2 ± 0 14 ± 3
aData from one of the experiments done to obtain RNA for microarray analysis;
data for yopM-1 Y. pestis were pooled from three experiments. The 1-h data
came from three experiments for yopM-1 Y. pestis and 2 for the parent Y. pestis
KIM5.
FIGURE 3 | Flow cytometric analysis of CD11b+ cell populations
after 1 h infection. C57BL/6 mice were infected for 1 h with 106
thermally-induced parent or yopM-1 Y. pestis, and CD11b+ cells were
obtained from spleens as described in the legend to Figure 2. Samples
were analyzed by flow cytometry for the presence of Ly6G, CD11b, Gr1,
CD11c, and for staining by EMA. The bars represent the averages ± SD of
the percent live leukocytes. Solid bars, mice infected with parent Y. pestis
(pooled data from two experiments and 8 mice); open bars, mice infected
with yopM-1 Y. pestis (pooled data from three experiments and 12 mice).
MOI (30–40) with Y. pestis KIM8-3003.12, which lacks all 6
effector Yops and also the surface protease Pla that can degrade
Yops (Sodeinde et al., 1988). yopM was overexpressed in trans
on pYopM, or the yersiniae contained only the empty vector.
The bacteria were given a 1-h induction at 37◦C to prime for
rapid delivery of YopM upon cell contact while retaining most of
the reactogenic lipid A form characteristic of growth at ambient
temperature (Rebeil et al., 2004). This was to provide a proin-
flammatory stimulus against which the effect of YopM might
be revealed, because YopM would normally be functioning in a
proinflammatory environment in-vivo. In these experiments the
use of cytochalasin D to prevent engulfment of the bacteria was
crucial, because these yersiniae lacked the antiphagocytic Yops.
Table 9 shows the results. BMMs infected for 1 h showed
strongly upregulated expression of Egr1 and a trend toward lower
expression when infected with the pYopM-containing Y. pestis
KIM8-3003.12 compared to the vector-only control strain, but
the effect was less than 2-fold and not statistically significant.
As expected, Egr1 expression had declined by 3 h and further by
6 h of infection. No YopM-related differences were found for the
other genes tested.
In J774A.1 cells infected for 1 h with either Y. pestis strain,
all genes tested except Ccl2 were expressed at levels significantly
greater than those in non-infected cells (highest P by t-test was
<0.005) (Table 9). Ccl2 expression was downregulated by infec-
tion with both YopM-expressing and control Y. pestis strains (P <
0.05). Interestingly, there were significant YopM-related differ-
ences in Egr1 expression, with 3.6-fold greater expression when
YopM was present at 1 h compared to cells infected with the
vector-only strain (P < 0.05). This pattern had reversed by 3 h
p.i. (P < 0.05), and expression was still strong, indicating that in
these cells YopM can have both early and delayed effects on Egr1.
No other genes tested showed YopM-related differences in expres-
sion at either 1 or 3 h. Cxcl10, which was assayed only after 6 h,
was downregulated in expression by infection (P < 0.05 for both
Y. pestis strains) but showed greater downregulation when YopM
was present (P < 0.05).
DISCUSSION
In this study we sought to identify early effects of Y. pestis YopM
in-vivo and characterize potential molecular pathways that YopM
modulates. We used a high-dose infection model to influence as
many of the direct target cells for Y. pestis as possible in their
natural context while retaining the phenotype of the yopM
strain. The synchronous infection due to the intravenous route
was then exploited in a series of molecular discovery assays. We
chose 1 and 16 h p.i. for analysis as times when the two bacterial
strains were present in the same numbers, but the yopM strain
had reached its peak and would not significantly increase there-
after due to the host response that normally is counteracted by
YopM (Figure 1A). The spleens of the mice at 16 h p.i. had simi-
lar acute inflammatory foci at the periphery of many follicles. The
numbers of live PMNs and inflammatory MOs were declining but
still elevated, and cells obtained by immunomagnetic beads were
viable.
CD11b+ CELLS PARTICIPATE IN THE EARLY HOST RESPONSE TO
SYSTEMIC PLAGUE
Although this model was not intended to replicate systemic
plague that occurs following low-dose peripheral infection, it did
provide the earliest available picture of host responses to sys-
temic plague and important new findings. A recent study of the
systemic phase of bubonic plague due to fully virulent Y. pestis
CO92 showed high levels of the PMN maturation factor G-CSF,
chemokines CXCL1 and CCL2, as well as cytokines IL-6 and Il-
1α in plasma (Demeure et al., 2012). These responses occurred by
day 2 after subcutaneous infection of rapid-responding plague-
resistant SEGmice but were delayed in susceptible C57BL/6 mice.
Systemic bacterial numbers were distinctively higher on day 2
in the SEG strain, and chemokine/cytokine response correlated
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Table 6 | Microarray results for 1-h infection, analyzed two waysa.
GenBank accession Symbol Name Fold change, parent/yopM-1
GENESPRING X WITH LOWESS NORMALIZATION
NM_007913 Egr1 Early growth response protein 1 0.24
NM_008300 Hspa4 Heat shock protein 4; synonym, Apg-2 0.44
NM_008737 Nrp Neuropilin-1 0.44
NM_011331 Ccl12 Cytokine (C-C motif) ligand 12 0.45
NM_011333 Ccl2 Cytokine (C-C motif) ligand 2 0.45
NM_010424 Hfe Hemochromatosis 0.46
NM_008064 Gaa Glucosidase, alpha, acid 0.50
NM_007457 Ap1s1 Adaptor protein complex AP-1, sigma 1 2.18
BIOCONDUCTOR WITH R SOFTWARE
NM_173740 Maoa Monoamine oxidase A 0.09
NM_133654 Cd34 CD34 antigen; sialomucin CD34 0.17
NM_007913 Egr1 Early growth response protein 1 0.17
aData for ≥2-fold differences between responses to parent and yopM-1 Y. pestis; current gene symbols and names obtained at MGI
(Mouse Genome Informatics, http://www.informatics.jax.org/). The complete normalized log ratio data as analyzed by GeneSpring X are available at
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41564
with bacterial burden. In our study with a high dose given intra-
venously, we also obtained high levels of G-CSF, CXCL1, CCL2,
and IL-6 in serum at 16 h p.i. in C57BL/6 mice (IL-1α was
not tested) and this agreement indicated that findings from this
model were not artifactual. Despite very high amounts of G-CSF
in serum at 16 h p.i., GM-CSF, a maturation factor for MOs, DCs,
and PMNs, was not detectable, and the MO maturation factor
M-CSF was present only at low levels. The CSFs are produced by
many cell types, including T cells, endothelial cells and stromal
cells in addition to Ms, and a circuit of amplification is hypoth-
esized in which stimulated Ms produce cytokines that in turn
stimulate CSF production from surrounding cells (Hamilton,
2008). The basis of selective expression of G-CSF in infection is
not fully understood, but it is part of the response to sepsis (e.g.,
Cebon et al., 1994) and is not unique to plague. A striking fea-
ture of our findings for sera at 16 h p.i. was the absence of the
pro-inflammatory cytokine IL-1β, which also was not elevated
in plasma or organs at any time in the study by Demeure et al.
(2012). Y. pestis has been found to stimulate caspase-1 activation
and IL-1β production in Ms (e.g., Bergsbaken and Cookson,
2007; Lilo et al., 2008); however, this effect apparently was not
dominant early in systemic plague.
We found a high level of the T helper 1 (Th1)-biasing cytokine
IFNγ and very high levels of two chemokines that are involved
in type 1 immune responses: CXCL9 and CXCL10 [not tested by
Demeure et al. (2012)]. These observations could indicate that an
early response to high numbers of Y. pestis includes mobilization
of a Th1-biased host response in addition to innate defenses, con-
sistent with the absence of elevated levels of the Th2 cytokines
IL-4 and IL-10 in sera. However, these chemokines increas-
ingly are being recognized as part of the early response to acute
microbial infections. Similarly to defensins, they can serve direct
anti-microbial roles against Gram-negative pathogens (Cole et al.,
2001), they are expressed early and promote bacterial clear-
ance of Klebsiella pneumoniae in experimental pneumonia (Zeng
et al., 2005), and they can promote survival against sepsis by
stimulating enhanced PMN recruitment and phagocytic activity
(Kelly-Scumpia et al., 2010). They may have protective potential
against systemic plague.
The chemokines/cytokines in sera represent the pooled out-
put of leukocytes and tissue cells in both liver and spleen, and
there were no large differences between sera of mice infected
with YopM+ compared to yopM-1 Y. pestis. To focus on the
direct effects of YopM on cells to which Y. pestis delivers Yops,
we measured chemokines/cytokines produced by a subpopula-
tion of splenic leukocytes. Y. pestis KIM5 was previously found
to deliver a tagged YopM selectively to CD11b+ CD11c− Ms,
CD11c+ CD11b− DCs, and Gr1+ cells (PMNs, MOs, and iDCs),
but not to CD4+ or CD8+ T cells or CD19+ B cells in spleens of
C57BL/6 mice (Marketon et al., 2005). We previously showed that
Ly6G+ PMNs are not required for the pathogenic effect of YopM
in spleens of C57Bl/6 mice infected with parent Y. pestis KIM5
compared to the yopM-1 strain (Ye et al., 2011). Accordingly,
we removed B, T, and dead cells along with Ly6G+ PMNs from
the splenic homogenates prepared from mice infected for a short
time with YopM+ or yopM-1Y. pestis, and recovered CD11b+
cells for analysis. Surprisingly, a third of the resulting cells, even
from non-infected mice, had the appearance of immature PMNs.
These cells were released by theMiltenyi dissociator protocol used
in these experiments: fewer such cells were present in the popu-
lations that we obtained for studies of gene expression with what
may be a gentler homogenizationmethod. Nonetheless, they were
present in all of the mice and could have participated in cytokine
production. At 16 h p.i. the CD11b+ cell population likely did
contribute to the high levels of CXCL9, CXCL10, and IFNγ that
were present in mice infected with either YopM+ or yopM-1 Y.
pestis. Further, the gene for CXCL10 was strongly induced after
6 h p.i. in total splenic leukocytes from SCID mice infected with
a high but non-lethal dose of Y. pestis lacking effector Yops or
expressing only YopM (R. L. Chelvarajan and S. C. Straley, unpub-
lished data). These findings provided additional support to the
idea that mice with systemic plague mobilize a Th1-biased innate
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Table 7 | Microarray results for 18-h infection, analyzed two waysa.
GenBank accession Symbol Name Fold change, parent/yopM-1
GENESPRING X WITH LOWESS NORMALIZATION
NM_009892 Chi3l3 Chitinase 3-like 3 0.06
NM_009140 Cxcl2 Chemokine (C-X-C motif) ligand 2 0.17
XM_489530 Igl-V1 Immunoglobulin lambda variable 1 0.19
NM_010876 Ncf1 Neutrophil cytosol factor 1 (p47-phox) 0.25
NM_001033632 Ifitm6 Interferon-induced transmembrane protein 6 0.31
NM_009982 Ctsc Cathepsin C 0.34
NM_008611 Mmp8 Matrix metallopeptidase-8 0.35
NM_010169 F2r Coagulation factor II (thrombin) receptor 0.36
NM_029612 Slamf9 SLAM family member 9 0.38
NM_009735 B2m Beta-2-microglobulin 0.39
NM_010583 Itk Il2-inducible T cell kinase 0.43
NM_027592 Taf9 TAF9 RNA polymerase II, TATA box binding protein 0.43
NM_013563 Il2rg Interleukin 2 receptor, gamma chain 0.43
NM_009684 Apaf1 Apoptotic protease activating factor 1 0.43
NM_009882 Cebpz CCAAT/enhancer binding protein zeta 0.44
NM_009192 Sla SRC-like-adapter (mSLAP) 0.44
NM_133948 Psip1 PC4 and SFRS1 interacting protein 1 0.44
NM_008394 Irf9 Interferon regulatory factor 9 0.44
NM_138952 Ripk2 Receptor (TNFRSF)-interacting serine/threonine-protein kinase 2 0.45
NM_016787 Bnip2 BCL2/adenovirus E1B interacting protein 2 0.45
NM_008390 Irf1 Interferon regulatory factor 1 0.46
NM_010480 Hsp90aa1 Heat shock protein 90, alpha (cytosolic) class A member 1 0.47
NM_010551 Il16 interleukin 16 0.47
NM_007452 Prdx3 Peroxiredoxin 3 0.47
NM_173740 Maoa monoamine oxidase A 3.52
NM_007641 Ms4a1 Membrane-spanning 4-domains, subfamily A, member 1 3.14
NM_008339 Cd79b CD79B antigen 2.42
BIOCONDUCTOR WITH R SOFTWARE
NM_007440 Alox12 Arachidonate-12 lipoxigenase 0.16
NM_009715 Atf2 Activating transcription factor 2 0.15
NM_001163247 Birc7 Baculoviral IAP repeat-containing 7 (livin) 0.13
NM_009902 Cldn3 Claudin 3 0.14
NM_008326 Irgm1 Immunity-related GTPase family M member 1 0.24
aData for ≥2-fold differences between responses to parent and yopM-1 Y. pestis; current gene symbols and names obtained at MGI
(Mouse Genome Informatics, http://www.informatics.jax.org/). The complete normalized log ratio data as analyzed by GeneSpring X are available at
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41564
response early in infection. The data also indicated that CD11b+
cells contribute to this response; but they did not point to a major
role for YopM in early chemokine/cytokine production.
THE EARLY TRANSCRIPTIONAL RESPONSE BY CD11b+ CELLS IN
SYSTEMIC PLAGUE
Ourmicroarray experiments tested whether the presence of YopM
affects expression of more than 1500 genes early in CD11b+ cells
from infected spleens. In these tests MOs/Ms constituted more
than two thirds of the CD11b+ population that we obtained.
Overall, the transcriptomic response was limited in scope, reflect-
ing the remarkably stealthy character of even high numbers of
Y. pestis. This phenomenon was noted in the microarray study
of gene expression in lymph nodes of rats with bubonic plague
(Comer et al., 2010). We found no genes with YopM-associated
significant changes in expression at 18 h p.i. There was, how-
ever, a YopM-associated downregulation of the gene for Egr1,
at 1 h p.i. This is the earliest time examined so far for Y. pestis
infection in-vivo and was possible because of the synchronous
infection used in this work. Egr1 is expressed in response to a wide
range of cellular stresses, including bacterial and parasitic infec-
tion (De Grado et al., 2001; Wiley et al., 2011), and its product
contributes to the regulation of hundreds of genes. It was identi-
fied as a member of a “core response module” in macrophages
consisting of 38 genes that all show differential responses to
stimuli and that tend to be targeted by pathogens (McDermott
et al., 2011). Proinflammatory genes that are upregulated by the
binding of Egr1 to their promoters encode TNFα, tissue factor,
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Table 8 | Relative transcript levelsa for a set of inflammation-related genes in splenic CD11b+ cells from infected mice.
Egr1 Tnfα Ccl2 Ccl3 IL1β
Non-infected 8.32 ± 2.11 1.07 ± 0.31 0.02 ± 0.01 0.73 ± 0.00 1.59 ± 0.03
1-h INFECTION—CONFIRMATION TESTSb
Parent 1.38 ± 0.20 1.14 ± 0.70 0.12 ± 0.00 0.63 ± 0.19 1.33 ± 0.52
yopM-1 9.40 ± 1.33∗ 1.70 ± 1.12 0.34 ± 0.05∗∗∗ 0.59 ± 0.06 2.88 ± 0.08∗∗
Ratio P/Mc 0.15 0.35 0.46
18-h INFECTIONb
Parent 2.20 ± 1.90 6.91 ± 1.58 13.02 ± 3.61 29.02 ± 16.23
yopM-1 1.92 ± 2.51 3.88 ± 2.62 13.38 ± 8.37 7.24 ± 4.35
aThe data are the expression values normalized to that for Ubc calculated as 100(2−(CPgene−CPUbc)), where CPUbc is the geometric mean from all experiments. Each
experiment was carried out at least twice, and the data are the averages ± SD.
bThe confirmation tests for 1 h infections were done by qRT-PCR on the RNA that was used for microarray. The data for non-infected and 18-h infected splenic
CD11b+ cells used RNA from independent sets of replicate experiments.
cRatio P/M is the ratio of average relative gene expression for mice infected by parent Y. pestis to that for mice infected with the yopM-1strain.
∗Data for parent differed significantly from those for yopM-1 at p < 0.05.
∗∗Data for parent differed significantly from those for yopM-1 at p < 0.005.
∗∗∗Data for parent differed significantly from those for yopM-1 at p < 5 × 10−6.
ICAM-1, CCL2, IL-8, and IL-6 (Guha et al., 2001; Shi et al., 2002;
Hoffmann et al., 2008). Accordingly, we included Tnfα, Ccl2, and
Il6 among the genes evaluated with in-vitro infection models.
YopM-ASSOCIATED GENE EXPRESSION IN BMMs AND J774A.1 CELLS
Wewanted to determine if altered gene expression due to the pres-
ence of YopM could be detected in an in-vitro infection model
with a single host cell type. Macrophages were chosen because
of their predominance in the populations studied by microar-
ray and because of the predicted central role of Egr1 in their
responses. Recent studies have found that YopM can sponta-
neously penetrate cells and cause ca. 2-fold downregulation of
Tnf α expression in HL60-derived macrophages by 6 h following
exposure to a high concentration (25μg ml−1) of pure protein
(Rüter et al., 2010). YopM also could significantly counteract the
stimulatory effect of LPS on mRNA levels for Tnf α and sev-
eral other cytokine genes in these cells (assayed after 16 h; Rüter
et al., 2010). Therefore, we revisited macrophage cell-culture
infection models to determine if delivery of YopM by infection
was downregulatory on gene expression. Despite using multi-
copy expression of yopM, a high MOI, inhibition of phagocytosis
to retain strong T3SS delivery by extracellular bacteria, and the
absence of other Yops that would compete for the T3SS chan-
nel or downregulate NF-κB and MAP kinase signaling, we found
only small downregulatory effects of YopM on Egr1 expression in
BMMs. However, J774A.1 cells did show significant YopM-related
early transcriptional responses. BMMs have amature macrophage
phenotype, whereas J774A.1 cells are intermediate MO-M-like
cells (Chamberlain et al., 2009), so it was reasonable to test them
as a model for cells from an early inflammatory focus. These cells
showed a biphasic response by Egr1 to the presence of YopM,
being initially upregulated compared to cells infected without
YopM delivery and then comparatively downregulated at 3 h p.i.
This is intriguing and raises the possibility that YopM has dis-
tinct effects depending on its state of trafficking in the cell, as
little YopM is observed in the nucleus by 1 h p.i., but a significant
amount can be there by 3 h (Skrzypek et al., 1998). We found no
significant YopM-related differences in Tnf α message levels at 3 h
p.i., perhaps because of the opposing effects on Egr1. It is mean-
ingful to test for Tnf α message this early in infection, because
it can be induced within an hour in response to stimuli (Espel
et al., 1996; Raabe et al., 1998), and a significant downregulating
effect was observed at 3 h by Rüter et al. (2010) in HL60-derived
macrophages treated with pure YopM. The other tested gene that
was differentially affected by the presence of YopM was Cxcl10 at
6 h p.i. This gene is not known to be directly regulated by Egr1;
however, a potential effect of YopM on Cxcl10 expression could
be real and worthy of further investigation, because CXCL10 lev-
els in serum were slightly lower at 16 h p.i. in mice infected by
the YopM+ strain. Our findings from J774A.1 cells are consis-
tent with an effect of YopM at the level of transcription early in
infection.
INTEGRATION OF THESE FINDINGS WITH THE GROWING PICTURE OF
YopM FUNCTION AT THE BIOCHEMICAL LEVEL
Egr1 transcription is activated in response to MAPK pathways
that lead to activation of the transcription factor Elk-1, such
as the Ras-Raf-MEK-ERK1/2 pathway (Guha et al., 2001). For
example, in response to LPS, ERK1/2-activated Elk-1, along with
serum response factor (SRF), bind and activate the Egr1 promoter
in THP-1 human monocytic leukemia cells (Guha et al., 2001).
The nuclear-localized transcription factor SRF is a substrate of
RSK1, and phosphorylation of SRF by activated RSK1 increases
the affinity of SRF for serum response elements in promoters
(Romeo et al., 2012) such as that for Egr1. YopM’s interac-
tion with RSK1 might downregulate Egr1 indirectly by forming
large complexes with RSK1 in the cytosol, thereby sequester-
ing this kinase there, and effectively preventing its access to the
nucleus and to SRF. Decreased levels of Egr1 could result in
reduced transcription of Egr1 target genes such as Tnf α, as seen
by Rüter et al. (2010). RSK1 is also involved in regulation of
IFNγ-dependent translation (Kroczynska et al., 2011); however,
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Table 9 | Relative gene expressiona in cultured Ms.
BMMsb Egr1 Tnfα Ccl2 Ccl3 IL1β Cxcl1
Non-infected 2.60 ± 0.06 2.71 ± 2.30 6.52 ± 2.56 36.0 ± 2.61 0.05 ± 0.01 0.08 ± 0.11
2-h INFECTION FOLLOWED BY 4-h INCUBATION
Parent 2.83 ± 1.18 417 ± 82.6 665 ± 211 1730 ± 165 258 ± 34.7 9.04 ± 7.63
yopM-1 2.52 ± 1.65 371 ± 36.4 674 ± 89.5 1580 ± 260 201 ± 26.4 9.11 ± 7.22
BMMsc
1-h INFECTION
Parent 2.23± 1.28
yopM-1 4.45± 4.37∗
BMMsd Egr1 Il6 Cxcl10 IL10
Non-infected 5.9 ± 4.6 0.0 ± 0.0 19.2 ± 26.1 0.1 ± 0.0
1-h INFECTION
pYopM 194 ± 102 0.1 ± 0.0 66.5 ± 49.4 21.2 ± 18.2
Vector 273 ± 140 0.0 ± 0.0 58.8 ± 40.8 15.2 ± 5.8
3-h INFECTION
pYopM 58.0 ± 25.6 535 ± 733 23.1 ± 12.0
Vector 55.2 ± 15.0 486 ± 464 17.5 ± 3.3
6-h INFECTION
pYopM 22.6 ± 12.2 6.1 ± 11.3 150 ± 104 15.5 ± 12.0
Vector 27.8 ± 10.9 3.7 ± 3.2 92.0 ± 32.1 14.6 ± 7.6
J774A.1 Cellsd Egr1 Il6 Cxcl10 Tnfα Ccl2 Ccl3
Non-infected 0.40 ± 0.40 0.40 ± 0.83 15.3 ± 12.3 517 ± 247 772 ± 681 2183 ± 1643
1-h INFECTION
pYopM 26.2 ± 32.6 4.8 ± 4.4 3400 ± 2080 75.4 ± 42.8 6560 ± 7900
Vector 7.2 ± 8.3∗ 3.9 ± 4.1 3810 ± 2480 67.9 ± 22.2 5560 ± 4650
3-h INFECTION
pYopM 33.7 ± 18.7 5050 ± 2820 5900 ± 570
Vector 55.9 ± 19.0∗ 3750 ± 1720 5170 ± 549
6-h INFECTION
pYopM 0.80 ± 1.1 1.9 ± 0.41 17,600 ± 23,700
Vector 0.20 ± 0.17 4.0 ± 1.8∗ 10,300 ± 11,500
aThe data are the expression values for the indicated genes normalized to that for Ubc calculated as 100(2−(CPgene−CPUbc)), where CPUbc is the geometric mean
from all experiments. Each experiment was carried out at least twice, and the data are the averages ± SD.
bBMMs were infected with parent or yopM-1 Y. pestis at an MOI of 10 in replicate experiments with at least duplicate infected cultures analyzed separately. In
these experiments, the medium was replaced after 2 h of infection with medium containing 5% FBS + 50 μg mL−1 gentamicin and 40 μg mL−1 chloramphenicol
to kill both extracellular and intracellular bacteria.
cBMMs were infected with parent or yopM-1 Y. pestis at an MOI of 10 in replicate experiments with quadruplicate infected cultures analyzed separately. The cells
were pretreated with, and infected in the presence of, cytochalasin D to prevent engulfment of the bacteria and maximize delivery of YopM.
d BMMs and J774A.1 cells were infected at an MOI of 30–40 with Y. pestis KIM8-3003.12 containing pYopM or the vector as indicated. The cells were pretreated
with, and infected in the presence of, cytochalasin D to prevent engulfment of the bacteria and maximize delivery of YopM. Gene expression in BMMs was assayed
in two to three experiments with two to four replicate cultures analyzed separately. For J774A.1 cells at 1 h, Egr1 and Ccl3 were measured in triplicate in seven
experiments and Ccl3 was measured in six experiments; the data for 3 h came from three experiments. At 6 h, numbers of experiments were 5 (Ccl3), 3 (Il6), and 2
(Cxcl10). Genes in non-infected J77A.1 cells were measured in 8 (Egr1), 8 (Il6), 5 (Cxcl10), 7 (Tnfα), 6 (Ccl2), and 10 (Ccl3) experiments.
∗Data for vector vs. pYopM infections differed significantly at p < 0.05.
such a role was not evident at 16 h of infection, when we charac-
terized chemokines/cytokines present in serum and produced by
CD11b+ cells. We believe that our findings link YopM’s binding
of RSK1 to indirect early effects on transcription.
However, binding to RSK1 does not account for all of YopM’s
pathogenic effect, because a YopM that was unable to bind
RSK1 still endowed Y. pseudotuberculosis with more pathogenic
potential than that of a strain without YopM (McCoy et al., 2010).
PRK2 binds at a more internal site on YopM than does RSK1 and
could be involved (McPhee et al., 2010). Further, YopM might
interact with numerous cellular components during its traffick-
ing, with potential pathogenic consequences (Skrzypek et al.,
1998); and YopM does go to the nucleus and likely does function
there.
THE LARGER PICTURE OF YopM FUNCTION
YopM is a major virulence factor in systemic plague due to
pgm Y. pestis in C57BL/6 mice; yet its phenotype in-vivo is not
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manifested until between days 1 and 2 after intravenous infec-
tion. Even in the present study with a dose of Y. pestis that
was more than a 1000-fold higher than used previously, there
was a delay in appearance of the growth-related phenotype.
These observations suggest that YopM’s target may be a com-
ponent of the host response that requires time to develop, and
that until this response occurs, YopM does not have a major
role at the level of transcription. YopM’s potential early effects
such as subtle downregulation of Tnf α in resident cells are not
likely to be YopM’s major function, due to redundancy to other
Yops that downregulate NF-κB and MAP kinase pathways as
well as the activity of the Y. pestis anti-inflammatory modified
lipid A.
The difficulty in establishing in-vitro models for dissecting
YopM’s major effects could in part arise from failure to repli-
cate the inflammatory character of the environment and/or cells
in which YopM functions. Perhaps that is why we obtained a
greater YopM-related response in immortalized monocyte-like
cells rather than BMMs, and why Rüter et al. (2010), by using
LPS stimulation of immortalized HL60-derived Ms and waiting
16 h, found downregulatory effects on cytokine genes as diverse
as TNFα, IL18, IL12p35, and Il15. The transcriptional effects
seen by Rüter et al. (2010) were relatively small, of the order of
2-fold or less. However, other stimulations of MO/M-lineage
cells might create target cells in which YopM shows a strong
effect.
Infection of mice with YopM-producing Y. pestis caused a
global effect in spleen that could protect the yopM-1 strain in
trans by preventing the stable accumulation of iDCs recruited
through CCR2 (Ye et al., 2011). There was an initial influx
of monocytes during the first 24 h in spleens of mice infected
with YopM+ Y. pestis, but by day 2 p.i. these cells as well as
NK cells were disappearing (Kerschen et al., 2004; Ye et al.,
2011). This means that at days 2 and 4 p.i. when RNA levels
were measured previously (Kerschen et al., 2004), the spleens
infected with the two Y. pestis strains contained qualitatively
different cell populations, and whether YopM caused the differ-
ences in transcription is not known. In contrast, in liver there
was no YopM-associated recruitment effect, the YopM+ strain
did not protect in trans, and PMN function was implicated as
being targeted directly or indirectly by YopM (Ye et al., 2011).
Nonetheless, the YopM-associated growth difference between
parent and yopM-1 strains occurs simultaneously in liver and
in spleen. We hypothesize that YopM’s molecular targets are the
same in the two organs even though there are organ-specific cellu-
lar responses. YopMmay have its primary role on activated cells or
may drive a local MDSC response (Haverkamp, 2011), and tran-
scriptional effects in these cells may be downregulated directly or
indirectly.
ACKNOWLEDGMENTS
This study was supported by funds from Public Health Services
NIAID grant 5R01AI67869 to SCS, DAC, and AMK with
a subcontract to Jenny P.-Y. Ting and W. June Brickey at
UNC-CH. Flow cytometry was conducted by the University
of Kentucky Flow Cytometry and Cell Sorting Core Facility,
which is supported in part by the Office of the Vice President
for Research, the Markey Cancer Center and a grant from the
NIH Shared Instrument Program (S10 RR026827-01A1). Cynthia
Long of the University of Kentucky Imaging Core Facility sec-
tioned and stained the infected spleens illustrated in this paper.
The R software through Bioconductor was employed to ana-
lyze hybridization signal intensities with the assistance of Drs.
Haibo Zhou and Baiming Zhou (UNC-CH). This work was
conducted without financial conflict of interest by any of the
authors.
REFERENCES
Akopyan, K., Edgren, T., Wang-Edgren,
H., Rosqvist, R., Fahlgren, A.,
Wolf-Watz, H., et al. (2011).
Translocation of surface-localized
effectors in type III secretion.
Proc. Natl. Acad. Sci. U.S.A. 108,
1639–1644.
Auffray, C., Sieweke, M. H., and
Geissmann, F. (2009). Blood mono-
cytes; development, heterogeneity,
and relationship with dendritic
cells. Annu. Rev. Immunol. 27,
669–692.
Becker, R. A., Chambers, J. M., and
Wilks, A. R. (1988). The New S
Language.New York, NY: Chapman
and Hall.
Benabdillah, R., Mota, L. J., Lüte-
lschwab, S., Demoinet, E.,
and Cornelis, G. R. (2004).
Identification of a nuclear localiza-
tion signal in YopM from Yersinia
spp. Microb. Pathog. 36, 247–261.
Bergsbaken, T., and Cookson, B. T.
(2007). Macrophage activation
redirects yersinia-infected host cell
death from apoptosis to caspase-1-
dependent pyroptosis. PLoS Pathog.
3:e161. doi: 10.1371/journal.ppat.
0030161
Brubaker, R. R. (1991). Factors pro-
moting acute and chronic diseases
caused by yersiniae. Clin. Microbiol.
Rev. 4, 309–324.
Burnett, S. H., Kerschen, E. J., Zhang,
J., Zeng, L., Straley, S. C., Kaplan,
A. M., et al. (2004). Conditional
macrophage ablation in trans-
genic mice expressing a Fas-based
suicide gene. J. Leukoc. Biol. 75,
612–623.
Cebon, J., Layton, J. E., Maher, D., and
Morstyn, G. (1994). Endogenous
haemopoietic growth factors in
peutropenia and infection. Br. J.
Haematol. 86, 265–274.
Chamberlain, L. M., Godek, M.
L., Gonzales-Juarrero, M., and
Grainger, D. W. (2009). Phenotypic
non-equivalence of murine
(monocyte-) macrophage in
biomaterial and inflammatory
models. J. Biomed. Mater. Res. A
88A, 858–871.
Cleveland, W. S. (1979). Robust locally
weighted regression and smoothing
scatterplots. J. Am. Stat. Assoc. 74,
829–836.
Cole, A. M., Ganz, T., Liese, A.
M., Burdick, M. D., Liu, L., and
Strieter, R. M. (2001). Interferon-
induced CXC chemokines display
defensin-like anti-microbial
activity. J. Immunol. 167,
623–627.
Comer, J. E., Sturdevant, D. E.,
Carmody, A. B., Virtaneva, K.,
Gardner, D., Long, D., et al.
(2010). Transcriptomic and innate
immune responses to Yersinia
pestis in the lymph node during
bubonic plague. Infect. Immun. 78,
5086–5098.
Conlan, J. W. (1997). Critical roles of
neutrophils in host defense against
experimental systemic infections
of mice by Listeria monocytogenes,
Salmonella typhimurium, and
Yersinia enterocolitica. Infect.
Immun. 2, 630–635.
Cowan, C., Philipovskiy, A. V., Wulff-
Strobel, C. R., Ye, Z., and Straley,
S. C. (2005). Anti-LcrV antibody
inhibits delivery of Yops by Yersinia
pestis KIM5 by directly promot-
ing phagocytosis. Infect. Immun. 73,
6127–6137.
De Grado, M., Rosenberger, C.
M., Gauthier, A., Vallance, B.
A., and Finlay, B. B. (2001).
Enteropathogenic Escherichia
coli infection induces expression
of the early growth response
factor by activating mitogen-
activated protein kinase cascades in
epithelial cells. Infect. Immun. 69,
6217–6224.
Demeure, C. E., Blanchet, C., Fitting,
C., Fayolle, C., Khun, H., Szatanik,
M., et al. (2012). Early systemic
bacterial dissemination and a rapid
innate immune response charac-
terize genetic resistance to plague
Frontiers in Cellular and Infection Microbiology www.frontiersin.org December 2012 | Volume 2 | Article 155 | 15
Uittenbogaard et al. Early host responses to YopM
of SEG mice. J. Infect. Dis. 205,
134–143.
Edgar, R., Domrachev, M., and Lash,
A. E. (2002). Gene expression
omnibus: NCBI gene expression
and hybridization array data
repository. Nucleic Acids Res. 30,
207–210.
Egan, C. E., Sukhumavasi, W., Bierly,
A. L., and Denkers, E. Y. (2008).
Understanding the multiple func-
tions of Gr-1+ cell populations dur-
ing microbial infection. Immunol.
Res. 40, 35–48.
Espel, E., Garcia-Sanz, J., Aubert, V.,
Menoud, V., Sperisen, P., Fernandez,
N., et al. (1996). Transcriptional
and translational control of TNF-α
gene expression in human mono-
cytes by major histocompatibility
complex II ligands. Eur. J. Immunol.
26, 2417–2424.
Evdokimov, A. G., Anderson, D. E.,
Routzahn, K. M., and Waugh,
D. S. (2001). Unusual molecular
architecture of the Yersinia pestis
cytotoxin YopM: a leucine-rich
repeat protein with the shortest
repeating unit. J. Mol. Biol. 312,
807–821.
Forman, S., Wulff, C. R., Myers-
Morales, T., Cowan, C., Perry, R.
D., and Straley, S. C. (2008). yadBC
of Yersinia pestis, a new virulence
determinant for bubonic plague.
Infect. Immun. 76, 578–587.
Frazer, L. C., O’Connell, C. M.,
Andrews, C. W. Jr., Zurenski,
M. A., and Darville, T. (2011).
Enhanced neutrophil longevity and
recruitment contribute to the sever-
ity of oviduct pathology during
Chlamydia muridarum infection.
Infect. Immun. 79, 4029–4041.
Guha, M., O’Connell, M. A., Pawlinski,
R., Hollis, A., McGovern, P., Yan, S.-
F., et al. (2001). Lipopolysaccharide
activation of the MEK-ERK1/2
pathway in human monocytic cells
mediates tissue factor and tumor
necrosis factor α expression by
inducing Elk-1 phosphorylation
and Egr-1 expression. Blood 98,
1429–1439.
Hamilton, J. A. (2008). Colony-
stimulating factors in inflammation
and autoimmunity. Nat. Rev.
Immunol. 8, 533–544.
Haverkamp, J. M. (2011). In-vivo func-
tion of myeloid-derived suppres-
sor cells is limited to the inflam-
matory site. Eur. J. Immunol. 41,
749–759.
Hentschke, M., Berneking, L., Campos,
C. B., Buck, F., Ruckdeschel, K., and
Aepfelbacher, M. (2010). Yersinia
virulence factor YopM induces sus-
tained RSK activation by interfer-
ing with dephosphorylation. PLoS
ONE 5:e13165. doi: 10.1371/jour-
nal.pone.0013165
Hoffmann, E., Ashouri, J., Wolter,
S., Doerrie, A., Dittrich-Brelholz,
O., Schneider, H., et al. (2008).
Transcriptional regulation of egr-1
by the interleukin-1-JNK-MKK7-c-
Jun pathway. J. Biol. Chem. 283,
12120–12128.
Kelly-Scumpia, K. M., Scumpia, P.
O., Delano, M. J., Weinstein, J.
S., Cuenca, A. G., Wynn, J. L.,
et al. (2010). Type I signaling in
hematopoietic cells is required for
survival in mouse polymicrobial
sepsis by regulating CXCL10. J. Exp.
Med. 207, 319–326.
Kerschen, E. J., Cohen, D. A., Kaplan,
A. M., and Straley, S. C. (2004). The
plague virulence protein YopM tar-
gets the innate immune response by
causing a global depletion of NK
cells. Infect. Immun. 72, 4589–4602.
Kroczynska, B., Joshi, S., Eklund, E. A.,
Verma, A., Kotenko, S. V., Fish, E.
N., et al. (2011). Regulatory effects
of ribosomal S6 kinase 1 (RSK1) in
IFNγ signaling. J. Biol. Chem. 286,
1147–1156.
Kung, J. T., Castillo, M., Kerbacher,
K., and Thomas, C. A. 3rd. (1991).
Subpopulations of CD8+ cytotoxic
T cell precursors collaborate in
the absence of conventional CD4+
helper T cells. J. Immunol. 146,
1783–1790.
Lilo, S., Zheng, Y., and Bliska, J. B.
(2008). Caspase-1 activation in
macrophages infected with Yersinia
pestis KIM requires the type III
secretion system effector YopJ.
Infect. Immun. 76, 3911–3923.
Lukaszewski, R. A., Kenny, D. J., Taylor,
R., Rees, D. G., Hartley, M. G., and
Oyston, P. C. (2005). Pathogenesis
of Yersinia pestis infection in BALB/c
mice: effects on host macrophages
and neutrophils. Infect. Immun. 73,
7142–7150.
Marketon, M. M., DePaolo, R. W.,
DeBord, K. L., Jabri, B., and
Schneewind, O. (2005). Plague
bacteria target immune cells during
infection. Science 309, 1739–1741.
McCoy, M. W., Marre, M. L., Lesser,
C. F., and Mecsas, J. (2010). The
C-terminal tail of Yersinia YopM is
critical for interacting with RSK1
and for virulence. Infect. Immun. 78,
2594–2598.
McDermott, J. E., Archuleta, M.,
Thrall, B. D., Adkins, J. N.,
and Waters, K. M. (2011).
Controlling the response: pre-
dictive modeling of a highly central,
pathogen-targeted core response
module in macrophage activa-
tion. PLoS ONE 6:e14673. doi:
10.1371/journal.pone.0014673
McDonald, C., Vacratsis, P. O., Bliska,
J. B., and Dixon, J. E. (2003).
The yersinia virulence factor YopM
forms a novel protein complex with
two cellular kinases. J. Biol. Chem.
278, 18514–18523.
McPhee, J. B., Mena, P., and Bliska, J.
B. (2010). Delineation of regions
of the Yersinia pestis YopM pro-
tein required for interaction
with the RSK1 and PRK2 host
kinases and their requirement
for interleukin-10 production
and virulence. Infect. Immun. 78,
3529–3539.
Nemeth, J., and Straley, S. C. (1997).
Effect of Yersinia pestis YopM on
experimental plague. Infect. Immun.
65, 924–930.
Perry, R. D., and Fetherston, J. D.
(1997). Yersinia pestis–etiologic
agent of plague. Clin. Microbiol.
Rev. 10, 35–66.
Philipovskiy, A. V., Cowan, C., Wulff-
Strobel, C. R., Burnett, S. H.,
Kerschen, E. J., Cohen, D. A., et al.
(2005). Antibody against V antigen
prevents Yop-dependent growth of
Yersinia pestis. Infect. Immun. 73,
1532–1542.
Poe, S. L., Arora, M., Oriss, T. B.,
Yarlagadda, M., Isse, K., Khare, A.,
et al. (2012). STAT1-regulated lung
MDSC-like cells produce IL-10 and
efferocytose apoptotic neutrophils
with relevance in resolution of
bacterial pneumonia. Mucosal
Immunol. doi: 10.1038/mi.2012.62.
[Epub ahead of print].
Raabe, T., Bukrinsky, M., and Currie,
R. A. (1998). Relative contribution
of transcription and transla-
tion to the induction of tumor
necrosis factor-α by lipopolysac-
charide. J. Biol. Chem. 273,
974–980.
Rebeil, R., Ernst, R. K., Gowen, B. B.,
Miller, S. I., and Hinnebusch, B. J.
(2004). Variation in lipid A struc-
ture in the pathogenic yersiniae.
Mol. Microbiol. 52, 1363–1373.
Reisner, B. S., and Straley, S. C.
(1992). Yersinia pestis YopM: throm-
bin binding and overexpression.
Infect. Immun. 60, 5242–5252.
Ribechini, E., Greifenberg, V.,
Sandwick, S., and Lutz, M. B.
(2010). Subsets, expansion and
activation of myeloid-derived
suppressor cells. Med. Microbiol.
Immunol. 199, 273–281.
Romeo, Y., Zhang, X., and Roux, P. P.
(2012). Regulation and function of
the RSK family of protein kinases.
Biochem. J. 441, 553–569.
Rüter, C., Buss, C., Scharnert, J.,
Heusipp, G., and Schmidt, M. A.
(2010). A newly identified bacte-
rial cell-penetrating peptide that
reduces the transcription of pro-
inflammatory cytokines. J. Cell Sci.
123, 2190–2198.
Shi, L., Kishore, R., McMullen,
M. R., and Nagy, L. E. (2002).
Lopopolysaccharide stimulation of
ERK1/2 increases TNF-α produc-
tion via Egr-1. Am. J. Physiol. Cell
Physiol. 282, C1205–C1211.
Skrzypek, E., Cowan, C., and Straley,
S. C. (1998). Targeting of the
Yersinia pestis YopM protein into
HeLa cells and intracellular traffick-
ing to the nucleus. Mol. Microbiol.
30, 1051–1065.
Skrzypek, E., Myers-Morales, T.,
Whiteheart, S. W., and Straley,
S. C. (2003). Application of a
Saccharomyces cerevisiae model to
study requirements for trafficking
of Yersinia pestis YopM in eucarotic
cells. Infect. Immun. 71, 937–947.
Sodeinde, O. A., Sample, A. K.,
Brubaker, R. R., and Goguen, J.
D. (1988). Plasminogen activa-
tor/coagulase gene of Yersinia pestis
is responsible for the degradation
of plasmid-encoded outer mem-
brane proteins. Infect. Immun. 56,
2749–2752.
Sukhatme, V. P. (1990). Early tran-
scriptional events in cell growth: the
Egr family. J. Am. Soc. Nephrol. 1,
859–866.
Une, T., and Brubaker, R. R. (1984).
In vivo comparison of avirulent
Vwa- and Pgm- or Pstr pheno-
types of yersiniae. Infect. Immun. 43,
895–900.
Viboud, G. E., and Bliska, J. B.
(2011). Yersinia outer proteins: role
in modulating host cell signaling
responses and pathogenesis. Annu.
Rev. Microbiol. 59, 69–89.
Wiley, M., Teygong, C., Phelps, E.,
Radke, J., and Blader, I. J. (2011).
Serum response factor regulates
immediate early host gene expres-
sion in Toxoplasma gondii-infected
host cells. PLoS ONE 6:e18335. doi:
10.1371/journal.pone.0018335
Yan, S.-F., Fujita, T., Lu, J., Okada,
K., Zou, Y. S., Mackman, N., et al.
(2000). Egr-1. Amaster switch coor-
dinating upregulation of divergent
gene families underlying ischemic
stress. Nat. Med. 6, 1355–1361.
Ye, Z., Kerschen, E. J., Cohen, D. A.,
Kaplan, A. M., van Rooijen, N.,
and Straley, S. C. (2009). Gr1+
cells control growth of YopM-
negative Yersinia pestis during
systemic plague. Infect. Immun. 77,
3791–3806.
Ye, Z., Uittenbogaard, A. M., Cohen,
D. A., Kaplan, A. M., Ambati, J.,
and Straley, S. C. (2011). Distinct
CCR2+ Gr1+ cells control growth
of the Yersinia pestis yopM mutant
Frontiers in Cellular and Infection Microbiology www.frontiersin.org December 2012 | Volume 2 | Article 155 | 16
Uittenbogaard et al. Early host responses to YopM
in liver and spleen during systemic
plague. Infect. Immun. 79, 674–687.
Zeng, X., Moore, T. A., Newstead,
M. W., Deng, J. C., Kunkel, S.
L., Luster, A. D., et al. (2005).
Interferon-inducible protein 10 but
not monokine induced by gamma
interferon, promotes protective type
I immunity in murine Klebsiella
pneumonia pneumonia. Infect.
Immun. 73, 8226–8236.
Zhang, Y., Szustakowski, J., and
Schinke, M. (2009). Bioinformatics
analysis of microarray data.Methods
Mol. Biol. 573, 259–284.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 14 September 2012; accepted:
22 November 2012; published online: 11
December 2012.
Citation: Uittenbogaard AM,
Chelvarajan RL, Myers-Morales T,
Gorman AA, Brickey WJ, Ye Z,
Kaplan AM, Cohen DA, Ting JP-Y
and Straley SC (2012) Toward a molec-
ular pathogenic pathway for Yersinia
pestis YopM. Front. Cell. Inf. Microbio.
2:155. doi: 10.3389/fcimb.2012.00155
Copyright © 2012 Uittenbogaard,
Chelvarajan, Myers-Morales, Gorman,
Brickey, Ye, Kaplan, Cohen, Ting and
Straley. This is an open-access article
distributed under the terms of the
Creative Commons Attribution License,
which permits use, distribution and
reproduction in other forums, provided
the original authors and source are cred-
ited and subject to any copyright notices
concerning any third-party graphics etc.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org December 2012 | Volume 2 | Article 155 | 17
